These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 21499248)

  • 41. The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus.
    Ueyama M; Nishida N; Korenaga M; Korenaga K; Kumagai E; Yanai H; Adachi H; Katsuyama H; Moriyama S; Hamasaki H; Sako A; Sugiyama M; Aoki Y; Imamura M; Murata K; Masaki N; Kawaguchi T; Torimura T; Hyogo H; Aikata H; Ito K; Sumida Y; Kanazawa A; Watada H; Okamoto K; Honda K; Kon K; Kanto T; Mizokami M; Watanabe S
    J Gastroenterol; 2016 Apr; 51(4):370-9. PubMed ID: 26337813
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic variations in death receptor domain 4 gene and the susceptibility to hepatitis C related hepatocellular carcinoma.
    Zayed SA; Zahran NM; Khorshied MM; Abdel-Aziz AO; Mahmoud O; Morsy SA; Shousha HI; Elbaz TM; Nabeel MM; Harb ARK
    J Med Virol; 2019 Aug; 91(8):1537-1544. PubMed ID: 30945308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
    Nischalke HD; Coenen M; Berger C; Aldenhoff K; Müller T; Berg T; Krämer B; Körner C; Odenthal M; Schulze F; Grünhage F; Nattermann J; Sauerbruch T; Spengler U
    Int J Cancer; 2012 Mar; 130(6):1470-5. PubMed ID: 21500195
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients.
    Elsayed HM; Nabiel Y; Sheta T
    Immunol Invest; 2017 Feb; 46(2):123-133. PubMed ID: 27819525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
    Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
    Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin-17 haplotyping predicts hepatocellular carcinoma in sofosbuvir, pegylated interferon-alpha-2a & ribavirin treated chronic hepatitis C patients.
    Mostafa AM; Saafan HA; Al-Tawashi AS; Kasem MH; Alaa AM; Eltobgy MM; Moubarak AS; Gharib MM; Awwad MA; Omar HM; El-Derany MO
    Virus Res; 2021 Jan; 292():198226. PubMed ID: 33171166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
    Motawi TK; Shaker OG; Ismail MF; Sayed NH
    Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The -94Ins/DelATTG polymorphism in NFκB1 promoter modulates chronic hepatitis C and liver disease progression.
    Fakhir FZ; Lkhider M; Badre W; Alaoui R; Pineau P; Ezzikouri S; Benjelloun S
    Infect Genet Evol; 2016 Apr; 39():141-146. PubMed ID: 26827631
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    Barooah P; Saikia S; Kalita MJ; Bharadwaj R; Sarmah P; Bhattacharyya M; Goswami B; Medhi S
    Viral Immunol; 2020; 33(6):457-467. PubMed ID: 32352886
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lower protein expression levels of MHC class I chain-related gene A in hepatocellular carcinoma are at high risk of recurrence after surgical resection.
    Huang CF; Wang SC; Chang WT; Yeh ML; Huang CI; Lin ZY; Chen SC; Chuang WL; Huang JF; Dai CY; Chen YL; Yu ML
    Sci Rep; 2018 Oct; 8(1):15821. PubMed ID: 30361527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis C.
    Huang CF; Huang CI; Yeh ML; Wang SC; Chen KY; Ko YM; Lin CC; Tsai YS; Tsai PC; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Yu ML
    Oncotarget; 2017 May; 8(20):32618-32625. PubMed ID: 28427234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcriptome-wide association study for persistent hepatitis B virus infection and related hepatocellular carcinoma.
    Han J; Chen C; Wang C; Qin N; Huang M; Ma Z; Zhu M; Dai J; Jiang Y; Ma H; Jin G; Shen H; Hu Z
    Liver Int; 2020 Sep; 40(9):2117-2127. PubMed ID: 32574393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aflatoxin B
    Chu YJ; Yang HI; Wu HC; Lee MH; Liu J; Wang LY; Lu SN; Jen CL; You SL; Santella RM; Chen CJ
    Eur J Cancer; 2018 May; 94():37-46. PubMed ID: 29533866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Understanding the host genetics of chronic hepatitis B and C.
    Thursz M; Yee L; Khakoo S
    Semin Liver Dis; 2011 May; 31(2):115-27. PubMed ID: 21538279
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Independent and additive effects of PNPLA3 and TM6SF2 polymorphisms on the development of non-B, non-C hepatocellular carcinoma.
    Raksayot M; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Treeprasertsuk S; Poovorawan Y; Tanaka Y; Tangkijvanich P
    J Gastroenterol; 2019 May; 54(5):427-436. PubMed ID: 30506232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers.
    Li S; Qian J; Yang Y; Zhao W; Dai J; Bei JX; Foo JN; McLaren PJ; Li Z; Yang J; Shen F; Liu L; Yang J; Li S; Pan S; Wang Y; Li W; Zhai X; Zhou B; Shi L; Chen X; Chu M; Yan Y; Wang J; Cheng S; Shen J; Jia W; Liu J; Yang J; Wen Z; Li A; Zhang Y; Zhang G; Luo X; Qin H; Chen M; Wang H; Jin L; Lin D; Shen H; He L; de Bakker PI; Wang H; Zeng YX; Wu M; Hu Z; Shi Y; Liu J; Zhou W
    PLoS Genet; 2012; 8(7):e1002791. PubMed ID: 22807686
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic variation in
    Buch S; Innes H; Lutz PL; Nischalke HD; Marquardt JU; Fischer J; Weiss KH; Rosendahl J; Marot A; Krawczyk M; Casper M; Lammert F; Eyer F; Vogel A; Marhenke S; von Felden J; Sharma R; Atkinson SR; McQuillin A; Nattermann J; Schafmayer C; Franke A; Strassburg C; Rietschel M; Altmann H; Sulk S; Thangapandi VR; Brosch M; Lackner C; Stauber RE; Canbay A; Link A; Reiberger T; Mandorfer M; Semmler G; Scheiner B; Datz C; Romeo S; Ginanni Corradini S; Irving WL; Morling JR; Guha IN; Barnes E; Ansari MA; Quistrebert J; Valenti L; Müller SA; Morgan MY; Dufour JF; Trebicka J; Berg T; Deltenre P; Mueller S; Hampe J; Stickel F
    Gut; 2023 Feb; 72(2):381-391. PubMed ID: 35788059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene polymorphisms of interleukin 28B and the risk to chronic hepatitis B virus infection in Thai.
    Kimkong I; Chankaew J; Kunanopparat A; Hirankarn N; Tangkijvanich P
    Tissue Antigens; 2015 Mar; 85(3):177-81. PubMed ID: 25664396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
    Abbas E; Shaker O; Abd El Aziz G; Ramadan H; Esmat G
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy.
    Shichi D; Kikkawa EF; Ota M; Katsuyama Y; Kimura A; Matsumori A; Kulski JK; Naruse TK; Inoko H
    Tissue Antigens; 2005 Sep; 66(3):200-8. PubMed ID: 16101831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.